Skip to main content
. Author manuscript; available in PMC: 2012 Oct 27.
Published in final edited form as: Nat Genet. 2011 Oct 16;43(11):1131–1138. doi: 10.1038/ng.970

Table 1.

Genetic loci associated with concentrations of liver enzymes in plasma at P < 1 × 10−8 in the GWAS

Region Sentinel SNP Position Alleles (R/E) EAF Effect (%, 95% confidence interval) P Genes of interest
ALT
4q22 rs6834314 88,432,832 G/A 0.75 2.6 (1.9–3.4) 3.1 × 10−9 HSD17B13ne, MAPK10e
8q24 rs2954021 126,551,259 G/A 0.50 1.6 (0.6–2.6) 5.3 × 10−9 TRIB1n
10q24a rs10883437 101,785,351 A/T 0.64 2.3 (1.4–3.1) 4.0 × 10−9 CPN1n
22q13a rs738409 42,656,060 C/G 0.23 6.0 (5.0–7.0) 1.2 × 10−45 PNPLA3nc, SAMM50c
ALP
1p36.12a rs1976403 21,639,040 A/C 0.40 3.6 (3.0–4.2) 1.8 × 10−50 ALPLo, NBPF3nce
2q24 rs16856332 169,548,820 G/T 0.96 3.9 (1.2–6.7) 1.6 × 10−9 ABCB11ng
6p22a rs1883415 24,599,454 A/C 0.33 3.1 (2.5–3.7) 5.6 × 10−26 ALDH5A1e, GPLD1nc
8p23 rs6984305 9,215,678 T/A 0.11 2.7 (1.1–4.4) 2.1 × 10−10 PPP1R3Bne
8q24 rs2954021 126,551,259 G/A 0.50 1.4 (0.5–2.3) 2.3 × 10−13 TRIB1n
9q21 rs10819937 103,263,054 G/C 0.17 2.5 (1.4–3.6) 1.0 × 10−9 ALDOBo, C9orf125n
9q34a rs579459 135,143,989 C/T 0.80 8.8 (7.4–10.2) 2.6 × 10−123 ABOn
10q21a rs7923609 64,803,828 A/G 0.50 2.2 (1.7–2.7) 5.9 × 10−23 JMJD1Cnce, NRBF2e
11q12 rs174601 61,379,716 C/T 0.35 1.7 (0.8–2.6) 2.6 × 10−9 C11orf10e, FADS1e, FADS2ne
11q.24 rs2236653 125,788,995 C/T 0.42 1.5 (0.6–2.5) 1.8 × 10−9 ST3GAL4n
16q22 rs7186908 70,777,874 G/C 0.24 2.0 (1.1–2.9) 4.8 × 10−9 HPRe, PMFBP1n
17p13 rs314253 7,032,374 T/C 0.33 2.1 (1.5–2.8) 8.4 × 10−12 ASGR1o, DLG4n
19q13a rs281377 53,898,415 C/T 0.43 1.8 (0.8–2.8) 1.1 × 10−15 FUT2nc
20p11 rs7267979 25,246,087 A/G 0.57 1.5 (0.9–2.0) 7.4 × 10−10 ABHD12ne, GINS1ce, PYGBo
GGT
1p36.13 rs1497406 16,377,907 A/G 0.56 3.8 (2.7–4.8) 2.8 × 10−19 RSG1e, EPHA2ne
1p22 rs12145922 88,918,822 C/A 0.61 2.8 (2.2–3.4) 3.8 × 10−11 CCBL2e, PKN2n
1p13 rs1335645 111,485,799 G/A 0.88 4.3 (3.5–5.2) 7.3 × 10−9 CEPT1ne, DENND2De
1q21 rs10908458 153,393,572 C/T 0.58 3.7 (3.1–4.2) 1.7 × 10−15 DPM3n, EFNA1ce, PKLRo
2p23 rs1260326 27,584,444 C/T 0.38 3.2 (2.4–4.0) 3.9 × 10−13 C2orf16e, GCKRnc
2q12 rs13030978 191,825,483 C/T 0.32 3.7 (2.8–4.6) 1.1 × 10−11 MYO1Bne, STAT4e
2q37 rs2140773 233,221,419 C/A 0.61 2.9 (2.3–3.5) 1.1 × 10−9 EFHD1ne, LOC100129166c
3q26 rs10513686 172,208,236 G/A 0.14 4.9 (4.0–5.7) 6.1 × 10−11 SLC2A2nc
4q31 rs4547811 147,014,071 T/C 0.18 6.4 (5.0–7.9) 2.5 × 10−27 ZNF827n
5p15 rs6888304 31,056,278 G/A 0.74 2.7 (2.0–3.5) 1.2 × 10−9 CDH6n
5q11 rs4074793 52,228,882 A/G 0.07 5.5 (3.3–7.7) 3.4 × 10−10 ITGA1n
6p12 rs9296736 54,032,656 C/T 0.31 3.0 (2.1–4.0) 2.6 × 10−9 MLIPne
7q11 rs17145750 72,664,314 T/C 0.86 4.5 (2.9–6.3) 2.9 × 10−9 MLXIPLnce
10q23 rs754466 79,350,440 A/T 0.24 3.5 (2.2–4.8) 6.4 × 10−10 DLG5n
12q24a rs7310409 119,909,244 A/G 0.59 6.8 (5.7–7.8) 7.0 × 10−45 HNF1Anc, C12orf27e
14q32 rs944002 102,642,568 A/G 0.21 6.3 (4.9–7.7) 5.8 × 10−29 C14orf73nc
15q21 rs339969 58,670,573 C/A 0.62 4.5 (3.9–5.1) 6.6 × 10−20 RORAn
15q23 rs8038465 71,765,390 C/T 0.39 2.4 (1.8–3.0) 1.4 × 10−9 CD276ne
16q23 rs4581712 79,055,102 C/A 0.27 3.2 (2.5–3.9) 3.1 × 10−9 DYNLRB2n
17q24 rs9913711 67,609,756 G/C 0.65 2.4 (1.8–3.0) 1.3 × 10−9 FLJ37644e, SOX9n
18q21.31 rs12968116 53,473,500 T/C 0.87 4.8 (2.8–6.7) 8.9 × 10−10 ATP8B1ncg
18q21.32 rs4503880 54,235,034 C/T 0.21 3.6 (2.5–4.7) 3.0 × 10−12 NEDD4Ln
19q13a rs516246 53,897,984 C/T 0.47 2.3 (1.8–2.9) 7.6 × 10−10 FUT2nc
22q11.21 rs1076540 16,819,958 T/C 0.78 4.8 (3.5–6.1) 9.6 × 10−17 MICAL3ne
22q11.23 rs2739330 22,625,286 C/T 0.42 3.7 (2.7–4.6) 1.7 × 10−9 DDTe, DDTLe, GSTT1e, GSTT2Bn, MIFe
22q11.23a rs2073398 23,329,104 C/G 0.34 12.3 (10.9–13.7) 1.1 × 10−109 GGT1ne, GGTLC2e

Alleles are given as the reference (R) allele/effect (E). EAF, effect allele frequency; effect is change in concentration of liver enzyme in plasma per copy of effect allele.

a

Previously reported associations. Annotation for genes of interest:

n

nearest;

e

expression QTL;

c

coding SNP;

g

GRAIL;

o

known biology.